Citations

Mayo Clinic

Showing 10 of 108572 citations.

Morphometric analysis of chronicity on kidney biopsy: a useful prognostic exercise
Đenić, Aleksandar , Asghar, Muhammad S , Denic, Aleksandar , Asghar, Muhammad Sohaib , Rule, Andrew D.

Clinical Kidney Journal | February 6, 2024 | Volume: 17 | Issue: 2 | Pages: No page available

10.1093/ckj/sfad226 | PMID 38327281 Get It

ABSTRACT Chronic changes on kidney biopsy specimens include increasing amounts of arteriosclerosis, glomerulosclerosis, interstitial fibrosis and tubular atrophy, enlarged nephron size, and reduced nephron number. These chronic changes are difficult to accurately assess by visual inspection but are reasonably quantified using morphometry. This review describes the various patient populations that have undergone morphometric analysis of kidney biopsies. The common approaches to morphometric analysis are described. The chronic kidney disease outcomes associated with various chronic changes by morphometry are also summarized. Morphometry enriches the characterization of chronicity on a kidney biopsy and this can supplement the pathologist's diagnosis. Artificial intelligence image processing tools are needed to automate the annotations needed for practical morphometric analysis of kidney biopsy specimens in routine clinical care.
Scalp Irradiation with 3D-Milled Bolus: Initial Dosimetric and Clinical Experience
Dibs, Khaled , Gogineni, Emile , Jhawar, Sachin R. , Baliga, Sujith , Grecula, J.C., Mitchell, Darrion , Palmer, Joshua D. , Haglund, Karl, Andraos, T.Y. , Zoller, Wesley , Ewing, Ashlee, Bonomi, Marcelo , Bhateja, Priyanka, Tinoco, Gabriel , Rocco, James W. , Old, Matthew , Gamez, Mauricio E. , Chakravarti, Arnab , Konieczkowski, David J. , Blakaj, Dukagjin , Jhawar, Sachin R , Mitchell, Darrion L , Palmer, Joshua D , Bhateja, Priyanka , Bonomi, Marcelo , Tinoco, Gabriel , Chakravarti, Arnab , Liebner, David A.

Cancers | February 6, 2024 | Volume: 16 | Issue: 4 | Pages: 688

10.3390/cancers16040688 | PMID 38398079 Get It

Background and purpose: A bolus is required when treating scalp lesions with photon radiation therapy. Traditional bolus materials face several issues, including air gaps and setup difficulty due to irregular, convex scalp geometry. A 3D-milled bolus is custom-formed to match individual patient anatomy, allowing improved dose coverage and homogeneity. Here, we describe the creation process of a 3D-milled bolus and report the outcomes for patients with scalp malignancies treated with Volumetric Modulated Arc Therapy (VMAT) utilizing a 3D-milled bolus. Materials and methods: Twenty-two patients treated from 2016 to 2022 using a 3D-milled bolus and VMAT were included. Histologies included squamous cell carcinoma (n = 14, 64%) and angiosarcoma (n = 8, 36%). A total of 7 (32%) patients were treated in the intact and 15 (68%) in the postoperative setting. The median prescription dose was 66.0 Gy (range: 60.0–69.96). Results: The target included the entire scalp for 8 (36%) patients; in the remaining 14 (64%), the median ratio of planning target volume to scalp volume was 35% (range: 25–90%). The median dose homogeneity index was 1.07 (range: 1.03–1.15). Six (27%) patients experienced acute grade 3 dermatitis and one (5%) patient experienced late grade 3 skin ulceration. With a median follow-up of 21.4 months (range: 4.0–75.4), the 18-month rates of locoregional control and overall survival were 75% and 79%, respectively. Conclusions: To our knowledge, this is the first study to report the clinical outcomes for patients with scalp malignancies treated with the combination of VMAT and a 3D-milled bolus. This technique resulted in favorable clinical outcomes and an acceptable toxicity profile in comparison with historic controls and warrants further investigation in a larger prospective study.
Projected Incidence of Hepatobiliary Cancers and Trends Based on Age, Race, and Gender in the United States
Storandt, Michael H. , Tella, Sri Harsha , Wieczorek, Mikolaj A. , Hodge, David O. , Elrod, Julia K. , Jin, Zhaohui , Hodge, David, Jin, Zhaohui , Rosenberg, Philip S. , Mahipal, Amit

Cancers | February 6, 2024 | Volume: 16 | Issue: 4 | Pages: 684

10.3390/cancers16040684 | PMID 38398075 Get It

Background: Identifying the projected incidence of hepatobiliary cancers and recognizing patient cohorts at increased risk can help develop targeted interventions and resource allocation. The expected incidence of subtypes of hepatobiliary cancers in different age groups, races, and genders remains unknown. Methods: Historical epidemiological data from the Surveillance, Epidemiology, and End Results (SEER) database was used to project future incidence of hepatobiliary malignancies in the United States and identify trends by age, race, and gender. Patients ≥18 years of age diagnosed with a hepatobiliary malignancy between 2001 and 2017 were included. US Census Bureau 2017 National Population projects provided the projected population from 2017 to 2029. Age–Period–Cohort forecasting model was used to estimate future births cohort-specific incidence. All analyses were completed using R Statistical Software. Results: We included 110381 historical patients diagnosed with a hepatobiliary malignancy between 2001 and 2017 with the following subtypes: hepatocellular cancer (HCC) (68%), intrahepatic cholangiocarcinoma (iCCA) (11.5%), gallbladder cancer (GC) (8%), extrahepatic cholangiocarcinoma (eCCA) (7.6%), and ampullary cancer (AC) (4%). Our models predict the incidence of HCC to double (2001 to 2029) from 4.5 to 9.03 per 100,000, with the most significant increase anticipated in patients 70–79 years of age. In contrast, incidence is expected to continue to decline among the Asian population. Incidence of iCCA is projected to increase, especially in the white population, with rates in 2029 double those in 2001 (2.13 vs. 0.88 per 100,000, respectively; p < 0.001). The incidence of GC among the black population is expected to increase. The incidence of eCCA is expected to significantly increase, especially among the Hispanic population, while that of AC will remain stable. Discussion: The overall incidence of hepatobiliary malignancies is expected to increase in the coming years, with certain groups at increased risk. These findings may help with resource allocation when considering screening, treatment, and research in the coming years.
Radiation Segmentectomy for the Treatment of Hepatocellular Carcinoma: A Practical Review of Evidence
Mourad, Sophia N., Toskich, Beau B. , Garza‐Ramos, Cynthia De la

Cancers | February 6, 2024 | Volume: 16 | Issue: 3 | Pages: 669

10.3390/cancers16030669 | PMID 38339418 Get It

Radiation segmentectomy is a versatile, safe, and effective ablative therapy for early-stage hepatocellular carcinoma. Advances in radiation segmentectomy patient selection, procedural technique, and dosimetry have positioned this modality as a curative-intent and guideline-supported treatment for patients with solitary HCC. This review describes key radiation segmentectomy concepts and summarizes the existing literary knowledgebase.
The Effect of Mixing Iodinated Contrast Media and Ultrasound Contrast Agents on Subharmonic Signals
Esposito, Cara , Tzan, Kenneth, Machado, Priscilla , Forsberg, Flemming , Dave, Jaydev K. , Dave, Jaydev K

Ultrasonic Imaging | February 6, 2024 | Volume: 46 | Issue: 2 | Pages: 130-134

10.1177/01617346241227971 | PMID 38318708 Get It

Subharmonic aided pressure estimation (SHAPE) is a technique that utilizes subharmonic signals from microbubble contrast agents for pressure estimation. Validation of the SHAPE technique relies on synchronous measurements of in vivo pressures using contrast microbubbles and a pressure catheter (reference standard). For the guidance and placement of pressure catheter in vivo, iodinated contrast is used with fluoroscopy. Therefore, during data acquisition for validation studies of the SHAPE technique, both contrast microbubbles and iodinated contrast are present simultaneously within the vasculature. This study aims to elucidate the effects of iodinated contrast (Visipaque, GE HealthCare) on subharmonic signal amplitude from contrast microbubbles (Definity, Lantheus Medical Imaging, Inc.). In an acrylic water tank, 0.06 mL of Definity and varied amounts of Visipaque (0.14, 0.43, 0.85, and 1.70 mL) were added to 425 mL of deionized water. Ultrasound scanning was performed with a SonixTablet scanner (BK Medical Systems) using optimized parameters for SHAPE with Definity ( f transmit/receive = 3.0/1.5 MHz; chirp down pulse). Subharmonic data was acquired and analyzed at 9 different incident acoustic outputs ( n = 3). Results showed an increase in subharmonic signal amplitude from Definity microbubbles in the presence of 0.14 mL Visipaque by 2.8 ± 1.3 dB ( p < .001), no change with 0.85 mL Visipaque (0.7 ± 1.2 dB; p = .09) and a decrease in subharmonic amplitude in the presence of 1.70 mL Visipaque by 1.9 ± 0.7 dB ( p < .001). While statistically significant effect on subharmonic signal amplitude of Definity microbubbles was noted due to the mixture, the magnitude of the effect was minimal (~2.8 dB) and unlikely to impact in vivo SHAPE measurements.
(079) Stripping vs Ligation of Vas Deferens in Microscopic Denervation of Spermatic Cord in Men with Chronic Orchialgia: A Multicenter Study
El‐Achkar, Adnan , Hammad, Mustafa , Barham, David , Hsieh, Michael H. , Ziegelmann, Matthew , Smith, Ryan P. , Bernie, Helen L. , Raheem, O., Hotaling, James M. , Yafi, Faysal A. , Hammad, Muhammed , Hammad, Muhammed A M , Hammad, M, Mills, James L. , Raheem, O, Fendereski, Kiarad

The Journal of Sexual Medicine | February 6, 2024 | Volume: 21 | Issue: Supplement_1 | Pages: No page available

10.1093/jsxmed/qdae001.075 Get It

Abstract Introduction Microdenervation of the spermatic cord (MSCD) is an effective treatment modality for men with intractable scrotal content pain. For patients not interested in preserving fertility, some centers advocate ligation of the vas during denervation while others perfer stripping of the Vas deferens to preserve the vasal artery, hence preserving vasculature to testis and possibly decreasing post operative congestion pain. Objective This multicenter study analyzes outcomes of patients that underwent MSCD by either stripping or ligating the vas deferens Methods A retrospective chart review of 85 patients who underwent MSCD from 2020-2023 was performed. Patients’ demographics including history of prior surgical procedures was recorded. Response to surgery was evaluated as either complete resolution of pain, partial resolution of pain or no improvement in pain. Results 85 patients underwent MSCD with a median (IQR) age of 36 (25.5-46.5) years and median duration of pain of 16 months. 37 patients underwent stripping of vas while 48 underwent ligation of vas during MSCD. Median follow up was 12 months. 21(43.5%) patients had prior inguinal scrotal surgery in ligation group compared to 5 (13.5%) in the stripping group p=0.003. The etiology of pain was similar between the groups. The response to MSCD between the 2 groups was similar (p=0.968), with similar post op complications (Table 1). Conclusions In men with intractable chronic scrotal content with no interest in preserving fertility, ligation or stripping of the vas deferens yields similar outcomes with regards to pain resolution. Both techniques are safe with no reports of any testicular atrophy. Disclosure No.
Facial Myoclonus Status From Anoxic‐Ischemic Brain Injury Due to Cardiac Arrest
Itoh, Christopher Y. , Tsikvadze, Mariam , Fugate, Jennifer E. , Wijdicks, Eelco F. M. , Wijdicks, Eelco Fm , Itoh, Christopher Yuki

Neurology | February 5, 2024 | Volume: 102 | Issue: 4 | Pages: No page available

10.1212/wnl.0000000000209127 | PMID 38315957 Get It

Editorial Comment
Britton, Cameron J. , Potretzke, Aaron M.

Urology Practice | February 5, 2024 | Volume: 11 | Issue: 2 | Pages: 366-366

10.1097/upj.0000000000000507.02 | PMID 38315871 Get It

The Electrocardiogram at 100 Years: History and Future
Friedman, Paul A.

Circulation | February 5, 2024 | Volume: 149 | Issue: 6 | Pages: 411-413

10.1161/circulationaha.123.065489 | PMID 38315763 Get It

Analysis of demographics and the impact of adjuvant radiotherapy on a nationwide cohort of patients with high-grade spinal meningiomas
El-Hajj, Victor Gabriel , Saïdi, N. , Hoang, Harry , Graepel, Stephen , Elmi‐Terander, Adrian , Lehrer, Eric J. , Brown, Paul D. , Bydon, Mohamad , Al-Saidi, Neil Nazar, Graepel, Stephen P, Elmi-Terander, Adrian , El-Hajj, Victor Gabriel , Al-Saidi, Neil Nazar , Ghaith, Abdul Karim , Nguyen, Ryan H

Neuro-Oncology Advances | February 5, 2024 | Volume: 6 | Issue: 1 | Pages: No page available

10.1093/noajnl/vdae018 | PMID 38410135 Get It

Abstract Background Although typically benign, 5% of spinal meningiomas (SMs) present with higher-grade features (World Health Organization grades 2 and 3). High-grade SMs are poorly studied and the role of adjuvant radiotherapy in their management remains controversial. We hence aimed to study the demographic characteristics of this rare tumor and investigate the outcomes associated with the use of surgery with adjuvant therapy in contrast to surgery alone. Methods The National Cancer Database was queried for patients with SMs from 2004 to 2017. Basic statistics were used to identify differences between low- and high-grade tumors in terms of baseline characteristics. Surgery with and without adjuvant radiotherapy were compared after (1:1) propensity-score matching. Kaplan–Meier survival analysis was conducted to study overall survival. All analyses were performed on R. Results A total of 13 184 patients diagnosed with SMs were included, of whom only 5% (n = 669) had high-grade SMs. Patients with high-grade SMs presented at a younger median age (57 years [IQR: 44–68] versus 65 years [54–75]; P &lt; .001) and were more commonly males (33% vs 20%; P &lt; .001). After propensity-score matching, survival analysis revealed similar overall survival outcomes in patients with high-grade SM undergoing both surgery and radiotherapy as compared to those only receiving surgery (P = .19). Conclusions This study reveals major demographic differences between high- and low-grade SMs. There were no benefits associated with the use of adjuvant radiotherapy. However, due to confounding, overall survival outcomes between patients receiving surgery alone and those receiving surgery with adjuvant radiotherapy are not causally interpretable.